Investing in DarioHealth Corp. (DRIO)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)1.8651
Intrinsic value (DCF)1.7542
Graham-Dodd Method0.00-100
Graham Formula96.077711

Company description

DarioHealth Corp (ticker: DRIO) is a global digital health company that aims to revolutionize how people manage their chronic conditions. Founded in 2012, DRIO has developed a mobile platform that combines innovative technology, advanced data science, and personalized coaching to empower individuals with chronic conditions to take control of their health. Their flagship product, the Dario Blood Glucose Monitoring System, is a smart glucose meter that seamlessly connects to the Dario mobile app to provide real-time glucose readings, personalized insights, and unlimited test strips with no insurance or prescriptions required. This makes it easier and more convenient for people with diabetes to monitor their blood sugar levels and make informed decisions about their treatment. In addition to diabetes, DarioHealth also offers products and services for hypertension, weight management, and respiratory illnesses. With a strong focus on innovation and customer satisfaction, DRIO is continuously expanding its reach and partnerships globally. Their mission is to empower people to live better and healthier lives, and their innovative approach to chronic condition management has made them a leader in the digital health space.